Patents by Inventor Agnete B. FREDRICKSEN

Agnete B. FREDRICKSEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified Antibody
    Publication number: 20230048561
    Abstract: Recombinant antibody-based molecules that trigger both T-cell and B-cell immune responses are disclosed. The recombinant molecules are comprised by at least one targeting unit and at least one antigenic unit connected through a dimerization motif. Also disclosed are nucleic acid molecules encoding the recombinant antibody-based molecule and methods of treating multiple myeloma or lymphoma in a patient using the recombinant antibody-based molecules or the nucleic acid molecules.
    Type: Application
    Filed: March 8, 2022
    Publication date: February 16, 2023
    Applicant: NYKODE THERAPEUTICS ASA
    Inventors: Bjarne BOGEN, Agnete B. FREDRICKSEN, Inger SANDLIE